Neutrophil–lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma undergoing TAE combined with Sorafenib
Neutrophil–lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma undergoing TAE combined with Sorafenib
复制标题
DOI：
10.1007/s12032-014-0969-5
复制
发表时间：
2014-05
期刊：
影响因子：
3.4
通讯作者：
Kai Wei;Meng Wang;Wei Zhang;H. Mu;T. Song
中科院分区：
文献类型：
--
作者：
Kai Wei;Meng Wang;Wei Zhang;H. Mu;T. Song
